Ardent Health (NYSE:ARDT) Raised to “Hold” at BMO Capital Markets

Ardent Health (NYSE:ARDT) was upgraded by equities researchers at BMO Capital Markets to a “hold” rating in a research note issued on Tuesday, Zacks reports.

A number of other brokerages also recently issued reports on ARDT. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $13.00 price objective on shares of Ardent Health in a research report on Thursday, August 6th. Wall Street Zen downgraded Ardent Health from a “buy” rating to a “hold” rating in a research note on Sunday, July 12th. Zacks Research raised Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Monday, September 7th. Guggenheim raised their price target on Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Finally, Weiss Ratings lowered Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a research note on Tuesday, August 11th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Ardent Health currently has an average rating of “Hold” and an average price target of $12.79.

Ardent Health Stock Performance

ARDT stock opened at $10.65 on Tuesday. Ardent Health has a 1-year low of $7.71 and a 1-year high of $15.48. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.10 and a quick ratio of 1.99. The company has a market capitalization of $1.50 billion, a P/E ratio of 19.37, a PEG ratio of 3.10 and a beta of 0.71. The business has a 50-day moving average price of $10.85 and a 200 day moving average price of $9.93.

Ardent Health (NYSE:ARDT) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). The business had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. As a group, equities research analysts forecast that Ardent Health will post 0.96 EPS for the current fiscal year.

Hedge Funds Weigh In On Ardent Health

Several institutional investors and hedge funds have recently modified their holdings of the stock. Allworth Financial LP acquired a new stake in shares of Ardent Health during the 2nd quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd boosted its holdings in Ardent Health by 2,036.6% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 4,786 shares of the company’s stock worth $42,000 after buying an additional 4,562 shares in the last quarter. Integrated Wealth Concepts LLC acquired a new stake in Ardent Health during the second quarter valued at $57,000. Monetary Solutions Ltd purchased a new position in Ardent Health in the fourth quarter valued at $79,000. Finally, Abel Hall LLC acquired a new position in shares of Ardent Health in the first quarter worth about $87,000.

Ardent Health Company Profile

Ardent Health is a U.S. healthcare provider that owns and operates hospitals, outpatient facilities and other healthcare services. The company delivers a broad range of medical care, including emergency services, inpatient and outpatient treatment, primary care, specialty care, surgical services, behavioral health and urgent care.

Headquartered in Nashville, Tennessee, Ardent serves communities through a network of hospitals and healthcare sites in several states, including Texas, Oklahoma, New Mexico and Kansas.